Xilio Therapeutics, Inc.
XLO
Revenue
2.26M
▼-94.00k▼-3.99%
3 Months ChangeAssets
74.66M
▼-15.22M▼-16.93%
3 Months ChangeLiabilities
53.68M
▼-2.77M▼-4.91%
3 Months ChangeFree Cash Flow
-25.42M
▼-4.33M▼-20.54%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-13
Form 8-K
ID: 0001558370-24-012775
2024-08-08
Form 10-Q
ID: 0001558370-24-011471
2024-08-08
Form 8-K
ID: 0001558370-24-011470
2024-06-17
Form 8-K
ID: 0001558370-24-009247
2024-06-13
Form 8-K
ID: 0001558370-24-009138
2024-05-14
Form 10-Q
ID: 0001558370-24-008068
2024-05-14
Form 8-K
ID: 0001558370-24-008063
2024-04-01
Form 8-K
ID: 0001558370-24-004528
2024-03-28
Form 8-K
ID: 0001558370-24-004249
2024-03-28
Form 8-K
ID: 0001558370-24-004165